Plasma procurement and plasma product safety in light of the COVID ‐19 pandemic from the perspective of the plasma industry

Hyperimmune immunoglobulin for hospitalised patients with COVID-19 (ITAC): a double-blind, placebo-controlled, phase 3, randomised trial

(2022) Mark N. Polizzotto et al.   LANCET

High-dose immunoglobulins from convalescent donors for patients hospitalised with COVID-19

(2022) Cynthia So-Osman et al.   LANCET

Experience with COVID ‐19 convalescent plasma provides vital guidance to future pandemics

(2022) Jan Hartmann et al.   TRANSFUSION

Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19

(2021) Robert L. Gottlieb et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Antibodies to watch in 2021

(2021) Hélène Kaplon et al.   mAbs

Factors driving availability of COVID ‐19 convalescent plasma: Insights from a demand, production, and supply model

(2021) W. Alton Russell et al.   TRANSFUSION

Lessons learned in the collection of convalescent plasma during the COVID‐19 pandemic

(2021) Silvano Wendel et al.   VOX SANGUINIS

Changes in Purchases for Intensive Care Medicines During the COVID-19 Pandemic

(2021) Katherine Callaway Kim et al.   CHEST

Minipool testing for SARS‐CoV ‐2 RNA in United States blood donors

(2021) Sonia Bakkour et al.   TRANSFUSION

The impact of COVID ‐19 outbreak on the Transfusion Medicine Unit of a Northern Italy Hospital and Cancer Centre

(2021) Davide Schiroli et al.   VOX SANGUINIS

Association between convalescent plasma treatment and mortality in COVID-19: a collaborative systematic review and meta-analysis of randomized clinical trials

(2021) Cathrine Axfors et al.   BMC INFECTIOUS DISEASES

Early Transfusion of Convalescent Plasma Improves the Clinical Outcome in Severe SARS-CoV2 Infection

(2021) Eszter Fodor et al.   Infectious Diseases and Therapy

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

(2020) Chaolin Huang et al.   LANCET

Slowing decline in blood collection and transfusion in the United States – 2017

(2020) Jefferson M. Jones et al.   TRANSFUSION

COVID-19 and blood safety: help with a dilemma

(2020) Roger Y. Dodd et al.   TRANSFUSION MEDICINE REVIEWS

The Essential Role of Patient Blood Management in a Pandemic

(2020) Aryeh Shander et al.   ANESTHESIA AND ANALGESIA

Triage tool for the rationing of blood for massively bleeding patients during a severe national blood shortage: guidance from the National Blood Transfusion Committee

(2020) Heidi Doughty et al.   BRITISH JOURNAL OF HAEMATOLOGY

Laboratory Diagnosis of COVID-19: Current Issues and Challenges

(2020) Yi-Wei Tang et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Viral contamination in biologic manufacture and implications for emerging therapies

(2020) Paul W. Barone et al.   NATURE BIOTECHNOLOGY

Prepare to adapt: blood supply and transfusion support during the first 2 weeks of the 2019 novel coronavirus ( COVID ‐19) pandemic affecting Washington State

(2020) Monica B. Pagano et al.   TRANSFUSION

Google Trends as an early indicator for shortages of intravenous immunoglobulin ( IVIG )

(2020) Jan Hartmann   TRANSFUSION

Dwindling blood reserves: An ominous downside of COVID-19 pandemic

(2020) Sohail Kumar et al.   TRANSFUSION AND APHERESIS SCIENCE

Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China, January-March 2020: retrospective cohort study

(2020) Shufa Zheng et al.   BMJ-British Medical Journal

From SARS to SARS-CoV-2, insights on structure, pathogenicity and immunity aspects of pandemic human coronaviruses

(2020) Nikhil Kirtipal et al.   INFECTION GENETICS AND EVOLUTION

Effective coronavirus reduction by various production steps during the manufacture of plasma‐derived medicinal products

(2020) Tobias Schräder et al.   TRANSFUSION

Treatment for emerging viruses: Convalescent plasma and COVID-19

(2020) Bethany L. Brown et al.   TRANSFUSION AND APHERESIS SCIENCE

Supply and demand for plasma‐derived medicinal products – a critical re‐assessment amidst the COVID ‐19 pandemic

(2020) Jan Hartmann et al.   TRANSFUSION

Characterization of 100 sequential SARS‐CoV‐2 convalescent plasma donations

(2020) Christof Jungbauer et al.   TRANSFUSION

REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19

(2020) David M. Weinreich et al.   NEW ENGLAND JOURNAL OF MEDICINE

SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19

(2020) Peter Chen et al.   NEW ENGLAND JOURNAL OF MEDICINE

The Human Plasma Proteome Draft of 2017: Building on the Human Plasma PeptideAtlas from Mass Spectrometry and Complementary Assays

(2017) Jochen M. Schwenk et al.   JOURNAL OF PROTEOME RESEARCH

Effective inactivation of a wide range of viruses by pasteurization

(2017) Albrecht Gröner et al.   TRANSFUSION

Inactivation of Middle East respiratory syndrome coronavirus (MERS-CoV) in plasma products using a riboflavin-based and ultraviolet light-based photochemical treatment

(2016) Shawn D. Keil et al.   TRANSFUSION

Risk factors for retrovirus and hepatitis virus infections in accepted blood donors

(2014) Brian Custer et al.   TRANSFUSION

Pathogen inactivation and removal methods for plasma-derived clotting factor concentrates

(2013) Robert Klamroth et al.   TRANSFUSION

Discovery of Seven Novel Mammalian and Avian Coronaviruses in the Genus Deltacoronavirus Supports Bat Coronaviruses as the Gene Source of Alphacoronavirus and Betacoronavirus and Avian Coronaviruses as the Gene Source of Gammacoronavirus and Deltacoronavirus

(2012) P. C. Y. Woo et al.   JOURNAL OF VIROLOGY

Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia

(2012) Ali M. Zaki et al.   NEW ENGLAND JOURNAL OF MEDICINE

How much blood is needed?

(2010) E. Seifried et al.   VOX SANGUINIS